About IDEXX Laboratories, Inc. - Common Stock (IDXX)
Idexx Laboratories is a global leader in veterinary diagnostics, providing a wide range of innovative products and services that enhance animal health and well-being. The company develops and manufactures diagnostic tests and equipment for companion animals, livestock, and poultry, helping veterinarians and livestock producers make informed health decisions. Additionally, Idexx offers various software solutions for practice management and laboratory information, along with water testing services to ensure public safety and environmental protection. With a commitment to advancing veterinary medicine and improving animal care, Idexx plays a crucial role in the healthcare ecosystem for animals and the people who care for them. Read More
IDEXX Laboratories (IDXX) is a high-quality stock with strong revenue growth, exceptional profitability, and solid financial health, making it a compelling pick for long-term investors.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Andrew Emerson, Executive Vice President and Chief Financial Officer, and Tina Hunt, Executive Vice President, Global Strategy and Commercial, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 28, 2025 from 10:55 am – 11:25 am (EDT).
Stay updated with the movements of the S&P500 index in the middle of the day on Thursday. Discover which stocks are leading as top gainers and losers in today's session.
The company has adjusted its full-year revenue guidance to $4.1 billion to $4.21 billion, reflecting the benefits of foreign exchange impacts, up from its previous estimate of $4.06 billion to $4.17 billion.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financial results for Thursday, May 1, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
